Is Rocephin (ceftriaxone) effective against Candida glabrata?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rocephin (Ceftriaxone) Has No Activity Against Candida glabrata

Rocephin (ceftriaxone) is completely ineffective against Candida glabrata because it is an antibacterial cephalosporin antibiotic with no antifungal properties whatsoever. Ceftriaxone is active only against bacterial pathogens, primarily Gram-positive and Gram-negative aerobic bacteria, and has no mechanism of action against fungal organisms including any Candida species 1.

Why This Matters Clinically

  • Ceftriaxone is a third-generation cephalosporin designed to treat bacterial infections such as urinary tract infections, respiratory infections, skin and soft tissue infections, and bacteremia caused by susceptible bacteria 1, 2
  • Candida glabrata is a fungal pathogen that requires antifungal agents, not antibacterial agents, for treatment 3
  • Using ceftriaxone for a Candida glabrata infection would result in complete treatment failure and allow the infection to progress unchecked

Appropriate Treatment for Candida glabrata

For Candidemia/Invasive Infections:

  • First-line therapy: Echinocandins (caspofungin, micafungin, or anidulafungin) are recommended as initial treatment for C. glabrata bloodstream infections 4
  • Alternative: Amphotericin B deoxycholate (0.3-0.6 mg/kg daily) or lipid formulations of amphotericin B for fluconazole-resistant or echinocandin-resistant strains 4
  • Fluconazole is problematic because C. glabrata frequently demonstrates innate resistance or reduced susceptibility to azole antifungals 4, 3

For Urinary Tract Infections:

  • Fluconazole-susceptible organisms: Oral fluconazole 200 mg (3 mg/kg) daily for 2 weeks 4
  • Fluconazole-resistant C. glabrata: Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days OR oral flucytosine 25 mg/kg 4 times daily for 7-10 days 4

For Vaginal Infections:

  • First-line: Intravaginal boric acid 600 mg in gelatin capsule daily for 14 days 5
  • Alternative: Nystatin intravaginal suppositories 100,000 units daily for 14 days 5

Critical Clinical Pitfall

The most dangerous error would be assuming that a broad-spectrum antibiotic like ceftriaxone has any activity against fungal pathogens. Antibiotics and antifungals are completely different drug classes with distinct mechanisms of action 1, 3. Always confirm whether an infection is bacterial or fungal before selecting antimicrobial therapy, as using the wrong class will result in treatment failure and potential patient harm.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.